• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

    7/11/24 5:16:41 AM ET
    $ASNS
    $BSFC
    $CING
    $CTM
    Telecommunications Equipment
    Telecommunications
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASNS alert in real time by email

    Shares of WD-40 Company (NASDAQ:WDFC) rose sharply in today's pre-market trading after the company posted stronger-than-expected results for its third quarter on Wednesday.

    Quarterly sales came in at $155 million which beat the analyst consensus estimate of $145.8 million. WD-40 reported quarterly earnings of $1.46 per share which beat the analyst consensus estimate of $1.27 per share, according to data from Benzinga Pro.

    WD-40 shares jumped 12.5% to $247.20 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Volcon, Inc. (NASDAQ:VLCN) rose 65.8% to $6.05 in pre-market trading after declining over 6% on Wednesday.
    • Actelis Networks, Inc. (NASDAQ:ASNS) shares rose 47.7% to $2.32 in pre-market trading after the company announced it received a significant order valued at $260,000 to modernize the traffic systems in a major Mid-Atlantic county in the United States.
    • MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) gained 45.1% to $2.38 in pre-market trading after surging over 12% on Wednesday.
    • Blue Star Foods Corp. (NASDAQ:BSFC) shares rose 28% to $2.15 in pre-market trading after declining around 5% on Wednesday.
    • Kazia Therapeutics Limited (NASDAQ:KZIA) shares climbed 26.8% to $0.8478 in pre-market trading. Kazia Therapeutics shares jumped 248% on Wednesday after the company announced results from GBM-AGILE, a phase II/III study that included an evaluation of paxalisib versus standard of care for patients with glioblastoma.
    • Castellum, Inc. (NYSE:CTM) rose 15.8% to $0.2316 in pre-market trading. On Wednesday, Castellum said it retired its term loan with Live Oak Banking Company ahead of schedule.
    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) gained 14.9% to $0.5885 in pre-market trading after gaining over 5% on Wednesday.
    • NaaS Technology Inc. (NASDAQ:NAAS) shares gained 14.3% to $5.35 in pre-market trading after surging 44% on Wednesday.
    • PriceSmart, Inc. (NASDAQ:PSMT) rose 5.1% to $82.32 in pre-market trading as the company reported better-than-expected results for its third quarter on Wednesday. The company posted quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $1.01 per share.

    Losers

    • Inspire Veterinary Partners, Inc. (NASDAQ:IVP) shares fell 22.6% to $5.73 in pre-market trading after the jumping 110% on Wednesday. Inspire Veterinary Partners announced the closing of $6 million public offering.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares declined 14.7% to $1.45 in pre-market trading. Virpax Pharmaceuticals shares jumped over 46% on Wednesday after the company announced results for a Swine Model pilot study for Probudur.
    • Longeveron Inc. (NASDAQ:LGVN) shares fell 14.3% to $3.90 in pre-market trading. Longeveron shares jumped over 58% on Wednesday after the company announced that the FDA granted Regenerative Medicine Advanced Therapy designation to Lomecel-B for the treatment of mild Alzheimer’s Disease.
    • Cingulate Inc. (NASDAQ:CING) shares fell 14.1% to $0.5571 in pre-market trading after gaining 74% on Wednesday.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) fell 13.8% to $8.06 in pre-market trading after dipping around 48% on Wednesday.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) fell 11.4% to $0.4066 in pre-market trading after gaining over 20% on Wednesday.
    • Scisparc Ltd (NASDAQ:SPRC) shares fell 10.7% to $0.60 in pre-market trading. SciSparc recently signed a non-binding letter of intent to spin off its clinical-stage pharmaceutical portfolio and its equity stake in SciSparc Nutraceuticals.
    • SAI.TECH Global Corporation (NASDAQ:SAI) shares dipped 7% to $1.07 in pre-market trading after jumping more than 28% on Wednesday.
    • Newegg Commerce Inc (NASDAQ:NEGG) shares fell 9.1% to $1.00 in pre-market trading after declining 5% on Wednesday. Newegg Commerce, on Monday, announced that the presale for its tenth annual FantasTech Sales event is now live.
    • LiveWire Group, Inc. (NASDAQ:LVWR) shares declined 6.8% to $7.00 in pre-market trading. LiveWire Group is expected to release its second quarter financial results before the opening bell Thursday, July 25.

    Now Read This:

    • S&P 500 Settles Above 5,600 For First Time Ahead Of Inflation Data, Fear Index Moves To ‘Greed’ Zone
    Get the next $ASNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASNS
    $BSFC
    $CING
    $CTM

    CompanyDatePrice TargetRatingAnalyst
    Kazia Therapeutics Limited
    $KZIA
    2/6/2025$3.00Buy
    Maxim Group
    Cingulate Inc.
    $CING
    1/10/2025$12.00Buy
    ROTH MKM
    Longeveron Inc.
    $LGVN
    12/6/2024$10.00Buy
    ROTH MKM
    Cingulate Inc.
    $CING
    12/22/2023Buy → Hold
    Laidlaw
    PriceSmart Inc.
    $PSMT
    12/1/2023$82.00Buy
    Jefferies
    NaaS Technology Inc.
    $NAAS
    10/31/2023$4.50Buy
    Jefferies
    Newegg Commerce Inc.
    $NEGG
    2/6/2023$3.50Outperform
    Noble Capital Markets
    PriceSmart Inc.
    $PSMT
    11/29/2022$96.00 → $77.00Sector Outperform → Sector Perform
    Scotiabank
    More analyst ratings

    $ASNS
    $BSFC
    $CING
    $CTM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP and CFO Callahan Jennifer L. bought $24,515 worth of shares (4,864 units at $5.04), increasing direct ownership by 2,494% to 5,059 units (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:20 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Schaffer Shane J. bought $34,317 worth of shares (6,809 units at $5.04) (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:19 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Werth Peter J. bought $98,053 worth of shares (19,455 units at $5.04) (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:20 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASNS
    $BSFC
    $CING
    $CTM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group initiated coverage on Kazia Therapeutics with a new price target

    Maxim Group initiated coverage of Kazia Therapeutics with a rating of Buy and set a new price target of $3.00

    2/6/25 7:53:38 AM ET
    $KZIA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ROTH MKM initiated coverage on Cingulate with a new price target

    ROTH MKM initiated coverage of Cingulate with a rating of Buy and set a new price target of $12.00

    1/10/25 7:39:52 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ROTH MKM initiated coverage on Longeveron with a new price target

    ROTH MKM initiated coverage of Longeveron with a rating of Buy and set a new price target of $10.00

    12/6/24 7:54:21 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASNS
    $BSFC
    $CING
    $CTM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ASNS
    $BSFC
    $CING
    $CTM
    SEC Filings

    View All

    Newegg Expands Trade-In Program to Include Desktop Memory

    Newegg Commerce, Inc. (NASDAQ:NEGG), a global leader in computer and technology products, today announced the expansion of its Trade-In Program to include eligible desktop memory. The new Memory Trade-In Program allows customers to trade in qualifying DDR4 and DDR5 desktop memory kits and receive credit toward the purchase of new memory on Newegg.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260319886708/en/Newegg Launches Memory Trade-In Program The expansion builds on the success of Newegg's GPU Trade-In Program launched in 2023 and the CPU Trade-In Program introduced in 2024, further enhancing Newegg's ecosystem for upg

    3/19/26 9:00:00 AM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    Actelis Networks Reports 2025 Financial Results Highlighted by Strong Fourth Quarter Rebound

    SUNNYVALE, Calif, March 18, 2026 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today reported its financial results for the full year ended December 31, 2025, and provided business and corporate updates. Revenues for the fourth quarter of 2025 were approximately $1.4 million, representing an increase of 113% from $0.64 million in the third quarter of 2025. For the full year 2025, revenues were $3.7 million, compared to $7.8 million in the prior year. The decrease was primarily driven by two large deals in 2024 that did not repeat in 2025. In

    3/18/26 5:15:00 PM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

    KANSAS CITY, Kan., March 18, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop a pipeline of next-generation products, today reported financial results for the quarter ended December 31, 2025, and provided a corporate update. Highlights include recent U.S. and European patent developments, the closing of a $12 million private investment, and the acceptance of a New Drug Application (NDA) for its lead candidate, CTx-1301 (dexmethylphenidate HCl). Cingulate CEO Shane J. Schaffer stated, "Cingulate delivered on key inflection points throughout 2025 and this continues i

    3/18/26 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Actelis Networks Inc.

    8-K - ACTELIS NETWORKS INC (0001141284) (Filer)

    3/18/26 5:24:10 PM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    SEC Form 10-K filed by Actelis Networks Inc.

    10-K - ACTELIS NETWORKS INC (0001141284) (Filer)

    3/18/26 5:22:27 PM ET
    $ASNS
    Telecommunications Equipment
    Telecommunications

    SEC Form DEFA14A filed by Cingulate Inc.

    DEFA14A - Cingulate Inc. (0001862150) (Filer)

    3/18/26 4:30:04 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASNS
    $BSFC
    $CING
    $CTM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Wu Paul

    3 - Newegg Commerce, Inc. (0001474627) (Issuer)

    3/19/26 12:12:52 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Hou Montaque

    3 - Newegg Commerce, Inc. (0001474627) (Issuer)

    3/19/26 12:09:09 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Galkin Vladimir

    3 - Newegg Commerce, Inc. (0001474627) (Issuer)

    3/19/26 11:53:05 AM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    $ASNS
    $BSFC
    $CING
    $CTM
    Leadership Updates

    Live Leadership Updates

    View All

    WD-40 Company Announces Board Changes

    WD-40 Company (NASDAQ:WDFC), a global marketing organization dedicated to creating positive lasting memories by developing and selling products that solve problems in workshops, factories, and homes around the world, announced today the appointment of Ken Plunk to its board of directors, effective February 18, 2026. Mr. Plunk will serve as a member of the Audit and Finance Committees. Mr. Plunk is an experienced board member with deep expertise in finance, strategy, governance, and risk management. He is known for his ability to lead organizational transformations and execute strategic initiatives that improve financial performance and shareholder value across complex, global businesses.

    2/19/26 4:05:00 PM ET
    $WDFC
    Major Chemicals
    Industrials

    Longeveron® Appoints Stephen H. Willard as Chief Executive Officer

    Mr. Willard has a 30+ year track record of leadership across public and private sectors as CEO of multiple biotechnology and pharmaceutical firms, with an impressive history of delivering significant fundraises and strategic collaborationsCorporate focus on delivering top-line results from the pivotal Phase 2b clinical trial in Hypoplastic Left Heart Syndrome (HLHS), anticipated in the third quarter of 2026 Than Powell stepped down as interim CEO; will remain with the Company to support the leadership transition and continue his work in the Company's on-going business development activities MIAMI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerati

    2/13/26 4:30:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to build a pipeline of next-generation products, today announced financial results for the quarter ended September 30, 2025, and provided recent corporate highlights. Recent Highlights (Post-Q3) FDA Accepts NDA for CTx-1301; PDUFA Date Set for May 31, 2026In October of 2025, the U.S. Food and Drug Administration (FDA) accepted Cingulate's New Drug Application

    11/13/25 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASNS
    $BSFC
    $CING
    $CTM
    Financials

    Live finance-specific insights

    View All

    Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

    On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indicationELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacyClosed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused fundsCompany to host conference call and webcast today at 4:30 p.m. ET MIAMI, March 17

    3/17/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    WD-40 Company Declares Regular Quarterly Dividend and Schedules Second Quarter 2026 Earnings Conference Call

    WD-40 Company (NASDAQ:WDFC) today announced that its board of directors declared on Monday, March 16, 2026, a quarterly dividend of $1.02 per share, payable April 30, 2026, to stockholders of record at the close of business on April 17, 2026. The Company also announced that it has scheduled its second quarter 2026 earnings conference call for Thursday, April 9, 2026, at 2:00 p.m. PDT. On this call, management will discuss financial results, business developments, and other matters affecting the Company. Other forward-looking or material information may also be discussed. A live webcast of the earnings conference call will be available on the Company's investor relations website at http:

    3/16/26 6:34:00 PM ET
    $WDFC
    Major Chemicals
    Industrials

    Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026

    MIAMI, March 12, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report 2025 full year financial results and provide a business update on Tuesday, March 17, 2026 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET. Conference Call and Webcast Details: Conference Call Number:1.877.407.0789Conference ID:13758462  Call meTM Feature:Click HereWebcast:Click Here   An archived replay of the webcast will be available on the "Events & Presentations" sec

    3/12/26 9:00:00 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASNS
    $BSFC
    $CING
    $CTM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Newegg Commerce Inc.

    SC 13D/A - Newegg Commerce, Inc. (0001474627) (Subject)

    12/17/24 4:37:51 PM ET
    $NEGG
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by NaaS Technology Inc.

    SC 13G/A - NaaS Technology Inc. (0001712178) (Subject)

    11/14/24 9:58:25 PM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Blue Star Foods Corp.

    SC 13G/A - Blue Star Foods Corp. (0001730773) (Subject)

    11/14/24 7:34:10 PM ET
    $BSFC